Comprehensive statistical analysis of predictive markers to immune checkpoint inhibitors in patients with non-small cell lung cancer

被引：0
|
作者：
Hiltbrunner, S. [1 ]
Spohn, M-L. [2 ]
Wechsler, R. [2 ]
Sanoyan, D. Akhoundova [1 ]
Bankel, L. [1 ]
Kasser, S. [1 ]
Bihr, S. [1 ]
Britschgi, C. [1 ]
Maathuis, M. H. [2 ]
Curioni-Fontecedro, A. [1 ]
机构：
[1] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland
[2] Swiss Fed Inst Technol, Dept Math, Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22P
引用
收藏
页码：S1382 / S1382
页数：1
相关论文
共 50 条
  • [41] Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study
    Feng, Ying
    Wang, Liyu
    Zhu, Fan
    Shi, Jianming
    Wang, Yan
    Zhang, Yingru
    Chen, Xiaofeng
    Zhang, Luyao
    HELIYON, 2024, 10 (05)
  • [42] Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
    Alice Mogenet
    Pascal Finetti
    Emilie Denicolai
    Laurent Greillier
    Pascaline Boudou-Rouquette
    François Goldwasser
    Gwenael Lumet
    Michele Ceccarelli
    Daniel Birnbaum
    Davide Bedognetti
    Emilie Mamessier
    Fabrice Barlesi
    François Bertucci
    Pascale Tomasini
    Journal of Translational Medicine, 21
  • [43] Identification of a predictive circulating immunological signature of response to immune checkpoint inhibitors in non-small cell lung cancer
    Khatir, Wassila
    Humbert, Olivier
    Neels, Jaap
    Berland, Lea
    Benzaquen, Jonathan
    Rivera, Fabian Andres Gallardo
    Allegra, Maryline
    Salah, Myriam
    Tanga, Virginie
    Bordone, Olivier
    Fayada, Julien
    Lespinet-Fabre, Virginie
    Long-Mira, Elodie
    Lassalle, Sandra
    Brest, Patrick
    Vouret, Valerie
    Maniel, Charlotte
    Boutros, Jacques
    Heeke, Simon
    Hofman, Veronique
    Marquette, Charles-Hugo
    Hofman, Paul
    Ilie, Marius
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer
    M. Karayama
    J. Masuda
    K. Mori
    H. Yasui
    H. Hozumi
    Y. Suzuki
    K. Furuhashi
    T. Fujisawa
    N. Enomoto
    Y. Nakamura
    N. Inui
    T. Suda
    M. Maekawa
    H. Sugimura
    A. Takada
    Clinical and Translational Oncology, 2021, 23 : 418 - 423
  • [45] Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
    Mogenet, Alice
    Greillier, Laurent
    Denicolai, Emilie
    Barlesi, Fabrice
    Bertucci, Francois
    Finetti, Pascal
    Tomasini, Pascale
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
    Mogenet, Alice
    Finetti, Pascal
    Denicolai, Emilie
    Greillier, Laurent
    Boudou-Rouquette, Pascaline
    Goldwasser, Francois
    Lumet, Gwenael
    Ceccarelli, Michele
    Birnbaum, Daniel
    Bedognetti, Davide
    Mamessier, Emilie
    Barlesi, Fabrice
    Bertucci, Francois
    Tomasini, Pascale
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [47] Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer
    Karayama, M.
    Masuda, J.
    Mori, K.
    Yasui, H.
    Hozumi, H.
    Suzuki, Y.
    Furuhashi, K.
    Fujisawa, T.
    Enomoto, N.
    Nakamura, Y.
    Inui, N.
    Suda, T.
    Maekawa, M.
    Sugimura, H.
    Takada, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (02): : 418 - 423
  • [48] Comprehensive analyses of the clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.
    Ou, Qiyun
    Fu, Tuping
    Yu, Yunfang
    Lin, Dagui
    Gao, Quanlong
    Zhang, Yuxin
    Luo, Baoming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [49] Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
    Vansteenkiste, Johan F.
    ESMO OPEN, 2018, 3 (06)
  • [50] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Kobayashi, Haruki
    RESPIROLOGY, 2020, 25 (08) : 892 - 893
12345